Agenus reported $16.68M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US $ 296M 15M
Bristol Myers Squibb BMY:US $ 328M 2M
Chemocentryx CCXI:US $ 0.67M 0.03M
CSL CSL:AU $ 79.1M 500K
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 83.6M 3.3M
Flexion Therapeutics FLXN:US $ 6.29M 1.11M
Gilead Sciences GILD:US $ 250M 6M
Immunogen IMGN:US $ 2.75M 0.83M
Karyopharm Therapeutics KPTI:US $ 8.01M 3.01M
Northwest Biotherapeutics NWBO:US 1.6M 797K
Novartis NOVN:VX 202M 1000K
Novavax NVAX:US $ 5.18M 0.79M
Pfizer PFE:US $ 325M 9M
Regeneron Pharmaceuticals REGN:US $ 14.2M 0.2M
Rigel Pharmaceuticals RIGL:US $ 1.32M 0.44M
Veracyte VCYT:US $ 0.06M 0M
YTE INCY:US $ 0.44M 0.08M